Search
Now showing items 1-6 of 6
The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer
(2022-10-30)
The management of locally advanced muscle invasive bladder cancer (MIBC) often necessitates neo-adjuvant chemotherapy (NAC) to eliminate any micro-metastatic disease prior to definitive radical cystectomy (RC) and pelvic ...
Clinical outcomes of low‑pressure pneumoperitoneum in minimally invasive urological surgery
(2022-01-30)
The adoption of minimally invasive laparoscopic techniques has revolutionised urological practice. This necessitates a pneumoperitoneum (PNP) and the impact the PNP pressure has on post-operative outcomes is uncertain. ...
Has robotic prostatectomy determined the fall of the laparoscopic approach?
(2021-12-25)
Robotic Assisted Laparoscopic Prostatectomy (RALP) has revolutionised the surgical management of localised Prostate Cancer in the modern era. The surgeon is provided with greater precision, more versatile dexterity and an ...
Artificial Intelligence in Urological Oncology: An update and future applications
(2021-05-20)
There continues to be rapid developments and research in the field of Artificial Intelligence (AI) in Urological Oncology worldwide. In this review we discuss the basics of AI, application of AI per tumour group (Renal, ...
Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era
(2020-12-17)
The COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers ...
The emerging role of Artificial Intelligence in the fight against COVID-19
(2020-09-17)
The coronavirus disease 2019 (COVID-19) pandemic has generated large volumes of clinical data that can be an invaluable resource towards answering a number of important questions for this and future pandemics. Artificial ...